SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-003494
Filing Date
2021-02-01
Accepted
2021-02-01 08:10:51
Documents
12
Period of Report
2021-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K dvax-8k_20210129.htm   iXBRL 8-K 40898
  Complete submission text file 0001564590-21-003494.txt   172382

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dvax-20210129.xsd EX-101.SCH 5772
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20210129_lab.xml EX-101.LAB 19478
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20210129_pre.xml EX-101.PRE 11627
5 EXTRACTED XBRL INSTANCE DOCUMENT dvax-8k_20210129_htm.xml XML 3558
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 21574422
SIC: 2834 Pharmaceutical Preparations